文献速递间质性肺疾病

S100A3与S100A13双基因突变与不典型肺纤维化相关

An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13.
PubMed 文献 · Eur Respir J · 2019-07-18

在两个近亲家系中临床调查13例间质性肺病患者,9例发生呼吸衰竭并死亡。分子遗传学发现S100A3低功能变异与S100A13新截短突变以常染色体隐性方式共分离,患者成纤维细胞中两蛋白表达显著降低,伴钙稳态异常、线粒体失调及细胞外基质成分差异表达,提示双基因遗传参与肺纤维化病理生理。

要点

  • 早发型肺纤维化(12-15岁)伴牵拉性支气管扩张和早期2型呼吸衰竭构成新临床亚型。
  • S100A3低功能变异与S100A13截短突变以常染色体隐性方式共分离致病。
  • 患者成纤维细胞S100A3和S100A13表达显著降低,提示钙依赖治疗方向。

核心结论

  • S100A3与S100A13双基因突变共同遗传是相关肺纤维化的病理生理基础,伴两种蛋白显著降低,提示钙依赖的治疗策略。

研究设计与样本

  • 对来自两个无亲缘关系近亲家系的13例间质性肺病患者进行临床调查,其中9例发生呼吸衰竭并死亡。
  • 对患者全血或存档组织进行分子遗传学检测,并对患者来源成纤维细胞进行细胞生物学研究。

主要发现

  • 患者表现为早发型肺纤维化(12-15岁),影像学包括牵拉性支气管扩张、小叶内间隔增厚、次级肺小叶收缩(主要围绕支气管血管束)及早期2型呼吸衰竭(血二氧化碳升高)。
  • 分子遗传学发现S100A3低功能变异与S100A13新截短突变,均以常染色体隐性方式与疾病共分离;杂合携带者或野生型正常家系成员未受累。
  • 患者来源成纤维细胞中S100A3和S100A13表达显著降低,并显示细胞内钙稳态异常、线粒体失调及细胞外基质成分差异表达。

临床怎么用

  • 对早发型家族性肺纤维化伴牵拉性支气管扩张和早期2型呼吸衰竭者,可考虑S100A3与S100A13基因检测。
  • 识别该临床亚型有助于遗传咨询,因杂合携带者与野生型正常者未受累。
  • 患者成纤维细胞显示钙稳态异常,提示钙依赖的治疗方向值得进一步研究。

局限性

  • 研究仅基于两个近亲家系的13例患者,样本量有限。
  • 机制证据主要来自患者来源成纤维细胞,尚未在体内模型或更广泛人群中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary fibrosis is one of the leading indications for lung transplantation. The disease, which is of unknown aetiology, can be progressive, resulting in distortion of the extracellular matrix (ECM), inflammation, fibrosis and eventual death. METHODS: 13 patients born to consanguineous parents from two unrelated families presenting with interstitial lung disease were clinically investigated. Nine patients developed respiratory failure and subsequently died. Molecular genetic investigations were performed on patients' whole blood or archived tissues, and cell biological investigations were performed on patient-derived fibroblasts. RESULTS: The combination of a unique pattern of early-onset lung fibrosis (at 12-15 years old) with distinctive radiological findings, including 1) traction bronchiectasis, 2) intralobular septal thickening, 3) shrinkage of the secondary pulmonary lobules mainly around the bronchovascular bundles and 4) early type 2 respiratory failure (elevated blood carbon dioxide levels), represents a novel clinical subtype of familial pulmonary fibrosis. Molecular genetic investigation of families revealed a hypomorphic variant in S100A3 and a novel truncating mutation in S100A13, both segregating with the disease in an autosomal recessive manner. Family members that were either heterozygous carriers or wild-type normal for both variants were unaffected. Analysis of patient-derived fibroblasts demonstrated significantly reduced S100A3 and S100A13 expression. Further analysis demonstrated aberrant intracellular calcium homeostasis, mitochondrial dysregulation and differential expression of ECM components. CONCLUSION: Our data demonstrate that digenic inheritance of mutations in S100A3 and S100A13 underlie the pathophysiology of pulmonary fibrosis associated with a significant reduction of both proteins, which suggests a calcium-dependent therapeutic approach for management of the disease.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Al-Mutairy EA, Imtiaz FA, Khalid M, et al. An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13. Eur Respir J. 2019. PMID: 31073086. doi:10.1183/13993003.02041-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。